首页> 外文OA文献 >Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson’s Disease

【2h】

Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson’s Disease

机译：多巴胺D2 / D3具有有效的铁螯合物，抗氧化和神经保护性能的激动剂：帕金森病的症状和神经保护治疗潜在含义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sanjib Gogoi; Tamara Antonio; Subramanian Rajagopalan; Maarten Reith; Julie Andersen; Aloke K. Dutta;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson's Disease [J] . Sanjib Gogoi, Tamara Antonio, Subramanian Rajagopalan ChemMedChem . 2011,第6期

机译：具有强铁螯合，抗氧化和神经保护特性的多巴胺D2 / D3激动剂：帕金森氏病对症和神经保护性治疗的潜在意义
2. Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethy l)piperazin-1-yl)quinolin-8-ol and Its Analogues as Highly Potent Dopamine D2/D3 Agonists and as Iron Chelator: In Vivo Activity Indicates Potential Application in Symptomatic and Neuroprotective Therapy for Parkinson's Disease [J] . Ghosh B, Antonio T, Reith MEA, Journal of Medicinal Chemistry . 2010,第5期

机译：发现4-（4-（2-（（5-羟基-1,2,3,4-四氢萘-2-基）（丙基）氨基）乙基l）哌嗪-1-基）喹啉-8-ol和其类似物为强效多巴胺D2 / D3激动剂和铁螯合剂：体内活性表明其在帕金森氏病对症和神经保护疗法中的潜在应用
3. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin. [J] . Li C, Biswas S, Li X, Journal of Neuroscience Research . 2010,第11期

机译：新型D3多巴胺受体首选激动剂D-264：由1-甲基-4-苯基-1,2,3,6-四氢吡啶和乳腺素引起的帕金森氏病动物模型中神经保护作用的证据。
4. Dopamine D3 receptor: A neuroprotective treatment target in Parkinson's disease. [D] . Biswas, Swati. 2008

机译：多巴胺D3受体：帕金森氏病的神经保护治疗靶标。
5. Dopamine D2/D3 Agonists with Potent Iron Chelation Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinsons Disease [O] . Sanjib Gogoi, Tamara Antonio, Subramanian Rajagopalan, -1

机译：多巴胺D2 / D3具有有效的铁螯合物抗氧化和神经保护性能的激动剂：帕金森病的症状和神经保护治疗潜在含义
6. A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinsons Disease [O] . -1

机译：一种新的铁（II）霍美激动剂螯合剂作为帕金森病的潜在症状和神经保护治疗剂

Dopamine D2/D3 Agonists with Potent Iron Chelation, Antioxidant and Neuroprotective Properties: Potential Implication in Symptomatic and Neuroprotective Treatment of Parkinson’s Disease

著录项

引文网络

相似文献

相关主题

期刊订阅